Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Condition:   Cystic Fibrosis
Interventions:   Drug: N6022;   Drug: Normal saline
Sponsors:   N30 Pharmaceuticals, Inc.;   N30 Pharmaceuticals, Inc.
Recruiting – verified September 2013

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

  

  

  

two × five =